NOE — Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2 Class II

FDA Device Classification

Classification Details

Product Code
NOE
Device Class
Class II
Regulation Number
866.5600
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, is intended to measure lipoprotein-associated phospholipase A2 in human plasma in conjunction with clinical evaluation and other patient risk factors including biochemical analyses as an aid in predicting risk for coronary heat disease. This device differs from the classification regulation in that it is a different analyte, thus a NEW marker for predicting risk of coronary heart disease. This device is measuring an enzyme that is produced by macrophages where as the regulation is for the measurement of a lipoprotein.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K203136diazyme laboratoriesDiazyme PLAC® Test for Lp-PLA2 ActivityAugust 6, 2021
K141575diadexusPLAC TEST FOR LP-PLA2 ACTIVITYDecember 15, 2014
K101853diadexusPLAC TEST REAGENT KIT, MODELS 90107, 90112, 90115, 90116, 10-0112, 10-0113, 10-0January 3, 2011
K072599diadexusPLAC TEST REAGENT KIT,CALIBRATOR KIT, LP-PLA2 CONTROL KIT, MODEL(S) 90107,90109,December 20, 2007
K062234diadexusMODIFICATION TO DIADEXUS PLAC TESTSeptember 11, 2006
K050523diadexusDIADEXUS PLAC TESTJune 15, 2005
K040101diadexusMODIFICATION TO DIADEXUS PLAC TESTFebruary 5, 2004
K030477diadexusDIADEXUS PLAC TESTJuly 18, 2003